Ji-Hyun Jang

Health Canada, University of British Columbia

Papers

3

Total Citations

29

H-Index

3

About

Dr. Ji-Hyun Jang is a leading gynecologic oncologist whose research centers on optimizing surgical outcomes for cervical cancer, with a particular focus on the comparative effectiveness of minimally invasive versus open surgical approaches. As a key contributor to the Canadian Cervical Cancer Collaborative (4C), Dr. Jang has produced landmark studies that challenge and refine clinical practice. Her most cited work, a 2022 study comparing abdominal, minimally invasive, and combined vaginal-laparoscopic hysterectomy for stage IAI/IA2 cervical cancer (15 citations), provides critical evidence on surgical safety and efficacy. Dr. Jang’s subsequent 2023 studies further illuminate the oncologic implications of surgical approach, demonstrating that minimally invasive surgery for macroscopic cervical cancer may worsen outcomes, while preoperative conization could mitigate these risks. Her investigations into surgical margin status across different approaches offer actionable insights for improving surgical precision. With a growing citation impact, Dr. Jang’s work is essential reading for clinicians and researchers navigating the complex trade-offs between surgical innovation and oncologic safety in early-stage cervical cancer management.

Research Focus

Key Achievements

3
H-Index
3
Papers
29
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study
15 citations · 2022
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Health Canada, University of British Columbia

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago